Go Pro

Zacks Research Analysts Lower Earnings Estimates for Revvity

Revvity logo with Healthcare background
Image from MarketBeat Media, LLC.

Key Points

  • Zacks Research lowered Revvity’s Q3 2026 earnings estimate to $1.27 per share from $1.30 and maintains a “Hold” rating. Analysts’ consensus rating is also “Hold,” with an average price target of $108.36.
  • Revvity’s latest quarterly results exceeded expectations, with EPS of $1.41 versus the $1.21 consensus and revenue of $729.69 million. However, revenue declined 1.3% year over year, and the company guided to fiscal 2026 EPS of $5.30–$5.40.
  • The stock rose 1.5% to $124.79, near its 52-week high, while institutional investors and hedge funds own 86.65% of outstanding shares. Revvity also declared a quarterly dividend of $0.07 per share.
  • Five stocks we like better than Revvity.

Revvity Inc. (NYSE:RVTY - Free Report) - Research analysts at Zacks Research dropped their Q3 2026 earnings per share estimates for shares of Revvity in a research report issued on Tuesday, August 25th. Zacks Research analyst Team now anticipates that the company will post earnings per share of $1.27 for the quarter, down from their prior estimate of $1.30. Zacks Research has a "Hold" rating on the stock. The consensus estimate for Revvity's current full-year earnings is $5.36 per share. Zacks Research also issued estimates for Revvity's FY2026 earnings at $5.38 EPS, Q2 2027 earnings at $1.51 EPS, Q3 2027 earnings at $1.42 EPS and Q2 2028 earnings at $1.62 EPS.

A number of other equities analysts also recently commented on the company. Wall Street Zen downgraded Revvity from a "buy" rating to a "hold" rating in a research report on Sunday, August 16th. Wolfe Research initiated coverage on Revvity in a report on Tuesday, June 2nd. They issued a "peer perform" rating on the stock. Robert W. Baird set a $117.00 price target on Revvity in a research note on Wednesday, May 6th. Weiss Ratings raised Revvity from a "sell (d+)" rating to a "hold (c-)" rating in a report on Thursday, July 30th. Finally, Evercore reaffirmed an "outperform" rating on shares of Revvity in a research report on Wednesday, August 5th. Three research analysts have rated the stock with a Buy rating and twelve have assigned a Hold rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of "Hold" and an average target price of $108.36.

Read Our Latest Stock Analysis on Revvity

Revvity Stock Up 1.5%

NYSE:RVTY opened at $124.79 on Wednesday. Revvity has a 52 week low of $81.22 and a 52 week high of $124.97. The stock's fifty day moving average is $112.37 and its two-hundred day moving average is $100.63. The stock has a market capitalization of $13.93 billion, a price-to-earnings ratio of 59.42, a price-to-earnings-growth ratio of 2.24 and a beta of 1.07. The company has a quick ratio of 1.50, a current ratio of 1.80 and a debt-to-equity ratio of 0.36.

Revvity (NYSE:RVTY - Get Free Report) last announced its quarterly earnings data on Tuesday, August 4th. The company reported $1.41 EPS for the quarter, topping analysts' consensus estimates of $1.21 by $0.20. Revvity had a return on equity of 8.34% and a net margin of 8.16%.The firm had revenue of $729.69 million for the quarter, compared to the consensus estimate of $702.96 million. During the same quarter last year, the business posted $1.18 earnings per share. The firm's revenue was down 1.3% compared to the same quarter last year. Revvity has set its FY 2026 guidance at 5.300-5.400 EPS.

Revvity Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, November 13th. Shareholders of record on Friday, October 23rd will be issued a $0.07 dividend. The ex-dividend date is Friday, October 23rd. This represents a $0.28 annualized dividend and a yield of 0.2%. Revvity's payout ratio is 13.33%.

Institutional Trading of Revvity

A number of hedge funds have recently added to or reduced their stakes in RVTY. New Mexico Educational Retirement Board raised its holdings in shares of Revvity by 1.9% in the 4th quarter. New Mexico Educational Retirement Board now owns 5,416 shares of the company's stock valued at $524,000 after acquiring an additional 100 shares in the last quarter. Allworth Financial LP increased its position in shares of Revvity by 8.9% in the fourth quarter. Allworth Financial LP now owns 1,275 shares of the company's stock worth $123,000 after purchasing an additional 104 shares during the last quarter. Northwestern Mutual Wealth Management Co. raised its stake in Revvity by 5.4% in the second quarter. Northwestern Mutual Wealth Management Co. now owns 2,074 shares of the company's stock valued at $231,000 after purchasing an additional 106 shares in the last quarter. EverSource Wealth Advisors LLC lifted its position in Revvity by 17.0% during the first quarter. EverSource Wealth Advisors LLC now owns 749 shares of the company's stock valued at $66,000 after purchasing an additional 109 shares during the last quarter. Finally, Angeles Wealth Management LLC lifted its position in Revvity by 2.0% during the second quarter. Angeles Wealth Management LLC now owns 5,804 shares of the company's stock valued at $646,000 after purchasing an additional 112 shares during the last quarter. 86.65% of the stock is owned by institutional investors and hedge funds.

About Revvity

(Get Free Report)

Revvity, Inc is a global provider of technology-enabled solutions for the life sciences, diagnostics and applied markets. The company develops and supplies a range of products and services, including reagents and consumables, laboratory instruments, workflow automation, software analytics and technical support. Its portfolio supports applications in drug discovery, genomics, cell biology research, environmental and food safety testing, industrial quality control and clinical diagnostics.

Tracing its heritage to Perkin-Elmer, founded in 1937, Revvity began trading on the New York Stock Exchange under the ticker symbol RVTY in January 2024 following a corporate rebranding.

Featured Stories

Earnings History and Estimates for Revvity (NYSE:RVTY)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Should You Invest $1,000 in Revvity Right Now?

Before you consider Revvity, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Revvity wasn't on the list.

While Revvity currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Don't Wait for the OpenAI IPO Cover

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines